Factitious Cushing syndrome

被引:42
作者
Cizza, G
Nieman, LK
Doppman, JL
Passaro, MD
Czerwiec, FS
Chrousos, GP
Cutler, GB
机构
[1] NIMH, CLIN NEUROENDOCRINOL BRANCH, BETHESDA, MD 20892 USA
[2] NIH, WARREN G MAGNUSON CLIN CTR, DEPT DIAGNOST RADIOL, BETHESDA, MD 20892 USA
关键词
D O I
10.1210/jc.81.10.3573
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There have been few reports of factitious Cushing syndrome. To characterize the clinical and laboratory features leading to this unusual diagnosis, we describe 6 patients (5 women, 1 man), ages 31-44, identified retrospectively among 860 patients evaluated for hypercortisolism at the National Institutes of Health Clinical Center. All six patients had multiple surgeries unrelated to Cushing syndrome and a history of depression or anxiety. Four patients had close contact with the medical profession, three a history of drug abuse, and three had undergone previous treatment for Cushing syndrome. The physical features of Cushing syndrome were variable and not helpful in the differential diagnosis with endogenous Cushing syndrome. Four patients had striking variability in urine-free cortisol (UFC) and 17-hydroxysteroid (17-OHCS) values from low to high. Adrenal computed tomography, performed in two patients, showed small adrenal glands (n = 1) or a left-sided mass (n = 1), and adrenal magnetic resonance imaging, performed in one patient, showed atrophic glands. Pituitary magnetic resonance imaging, carried out in four patients, was either normal (n = 1) or exhibited questionable signs of microadenoma (n = 3). Determination of synthetic glucocorticoids by high pressure liquid chromatography (HPLC) was positive in the four patients in whom it was performed. Factitious Cushing syndrome is a difficult diagnosis. To conserve time and resources, high pressure liquid chromatography analysis of urine steroids, the most definitive test for the factitious disorder, should be performed whenever there is clinical suspicion of glucocorticoid abuse.
引用
收藏
页码:3573 / 3577
页数:5
相关论文
共 19 条
  • [1] [Anonymous], 1994, Diagnostic and statistical manual of mental disorders
  • [2] ASHER R, 1951, LANCET, V260, P339
  • [3] THE METYRAPONE AND DEXAMETHASONE SUPPRESSION TESTS FOR THE DIFFERENTIAL-DIAGNOSIS OF THE ADRENOCORTICOTROPIN-DEPENDENT CUSHING SYNDROME - A COMPARISON
    AVGERINOS, PC
    YANOVSKI, JA
    OLDFIELD, EH
    NIEMAN, LK
    CUTLER, GB
    [J]. ANNALS OF INTERNAL MEDICINE, 1994, 121 (05) : 318 - 327
  • [4] THE CORTICOTROPIN-RELEASING HORMONE TEST IN THE POSTOPERATIVE EVALUATION OF PATIENTS WITH CUSHINGS-SYNDROME
    AVGERINOS, PC
    CHROUSOS, GP
    NIEMAN, LK
    OLDFIELD, EH
    LORIAUX, DL
    CUTLER, GB
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 65 (05) : 906 - 913
  • [5] BROWN RD, 1973, J CLIN ENDOCR METAB, V36, P445
  • [6] FACTITIOUS CUSHINGS-SYNDROME
    COOK, DM
    MEIKLE, AW
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 61 (02) : 385 - 387
  • [7] ADRENOCORTICOTROPIN STIMULATION TEST - EFFECTS OF BASAL CORTISOL LEVEL, TIME OF DAY, AND SUGGESTED NEW SENSITIVE LOW-DOSE TEST
    DICKSTEIN, G
    SHECHNER, C
    NICHOLSON, WE
    ROSNER, I
    SHENORR, Z
    ADAWI, F
    LAHAV, M
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 72 (04) : 773 - 778
  • [8] DOHERTY GM, 1990, SURGERY, V108, P1085
  • [9] MORBIDITY AND MORTALITY IN CUSHINGS-DISEASE - AN EPIDEMIOLOGIC APPROACH
    ETXABE, J
    VAZQUEZ, JA
    [J]. CLINICAL ENDOCRINOLOGY, 1994, 40 (04) : 479 - 484
  • [10] FACTITIOUS HYPOGLYCEMIA DUE TO SURREPTITIOUS ADMINISTRATION OF INSULIN - DIAGNOSIS, TREATMENT, AND LONG-TERM FOLLOW-UP
    GRUNBERGER, G
    WEINER, JL
    SILVERMAN, R
    TAYLOR, S
    GORDEN, P
    [J]. ANNALS OF INTERNAL MEDICINE, 1988, 108 (02) : 252 - 257